Cargando…
Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy
Despite recent advances, chronic heart failure remains a significant and growing unmet medical need, reaching epidemic proportions carrying substantial morbidity, mortality, and costs. A safe and convenient therapeutic agent that produces sustained inotropic effects could ameliorate symptoms and imp...
Autores principales: | Thomson, Kassandra S., Odom, Guy L., Murry, Charles E., Mahairas, Gregory G., Moussavi-Harami, Farid, Teichman, Sam L., Chen, Xiaolan, Hauschka, Stephen D., Chamberlain, Jeffrey S., Regnier, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444879/ https://www.ncbi.nlm.nih.gov/pubmed/28553667 http://dx.doi.org/10.1016/j.jacbts.2016.07.006 |
Ejemplares similares
-
Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate
por: Kolwicz, Stephen C., et al.
Publicado: (2019) -
Upregulation of Cardiomyocyte Ribonucleotide Reductase Increases
Intracellular 2 deoxy-ATP, Contractility, and Relaxation
por: Korte, F. Steven, et al.
Publicado: (2011) -
Cell based dATP delivery as a therapy for chronic heart failure
por: Mhatre, Ketaki N, et al.
Publicado: (2023) -
Screening of traditional Chinese medicine monomers as ribonucleotide reductase M2 inhibitors for tumor treatment
por: Qin, Ya-Ya, et al.
Publicado: (2022) -
Allosteric Inhibition of Human Ribonucleotide Reductase
by dATP Entails the Stabilization of a Hexamer
por: Ando, Nozomi, et al.
Publicado: (2015)